Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.

The survival of people with this stage of the disease is worse than many cancers – less than 50% will be alive five years ...

The peripheral nerves are located in the arms and legs ... viruses, autoimmune diseases, vitamin deficiencies and cancer treatments like chemotherapy. The most common type of peripheral neuropathy ...

Neuromuscular disorders can affect various parts of the peripheral nervous system, including nerves that control muscles, nerves that communicate sensory information back to the brain, the ...

The causal relationship of liver disease to neuropathy has been ... electrophysiologically to detect any evidence of peripheral neuropathy. Nerve conduction studies were performed in the upper ...

They placed central and peripheral nerve cells taken from rats together ... information in people suffering spinal injuries or other disorders, he suggested. More research will be needed to ...

It’s used primarily in people with chronic headache disorders for whom other treatments ... Uniquely, this approach is designed to stimulate the peripheral nerves in the upper arm.

Charcot-Marie-Tooth (CMT) disease, a group of heritable disorders that affect the peripheral nerves, is marked by specific genetic changes. Research by the team of Prof. Ludo Van Den Bosch (VIB-KU ...